Cargando…

Association between ABO blood group and HCV-related hepatocellular carcinoma risk in China

The ABO blood group has previously been reported to be associated with risk for certain malignancies; however, data about the risks for hepatocellular carcinoma (HCC) according to blood type are limited. Thus, we conducted a retrospective case–control study to investigate whether the ABO blood group...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xu, Xu, Hongqin, Ding, Zhongyang, Jin, Qinglong, Gao, Pujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266047/ https://www.ncbi.nlm.nih.gov/pubmed/27930575 http://dx.doi.org/10.1097/MD.0000000000005587

Ejemplares similares

Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis C patients in China
por: Li, Xu, et al.
Publicado: (2017)

ABO Blood Group and Diabetes Mellitus Influence the Risk for Pancreatic Cancer in a Population from China
por: Li, Xu, et al.
Publicado: (2018)

Red Blood Cell Distribution Width to Platelet Ratio is Related to Histologic Severity of Primary Biliary Cirrhosis
por: Wang, Huan, et al.
Publicado: (2016)

Platelet count to spleen thickness ratio is related to histologic severity of primary biliary cholangitis
por: Wang, Zhongfeng, et al.
Publicado: (2018)

Alpha-fetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinoma
por: Liu, Xu, et al.
Publicado: (2019)

Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients
por: Li, Xu, et al.
Publicado: (2019)

Liver cirrhosis: a risk factor for gallstone disease in chronic hepatitis C patients in China
por: Li, Xu, et al.
Publicado: (2017)

Chronic hepatitis C virus infection: Relationships between inflammatory marker levels and compensated liver cirrhosis
por: Li, Xu, et al.
Publicado: (2019)

Diabetes Mellitus is a Risk Factor for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection in China
por: Li, Xu, et al.
Publicado: (2018)

Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma
por: Ding,, Dongxiao, et al.
Publicado: (2023)

Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma
por: Liao, Weijia, et al.
Publicado: (2016)

Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study
por: Zhu, Yun-Feng, et al.
Publicado: (2019)

Combination therapy: Meta-analysis of the effects of TACE and cryoablation on hepatocellular carcinoma
por: Yuan-Dong, Sun, et al.
Publicado: (2019)

Prognostic value of inflammatory and nutritional markers for hepatocellular carcinoma
por: Xu, Yingying, et al.
Publicado: (2021)

Circulating MicroRNAs as Biomarkers in Hepatocellular Carcinoma Screening: A Validation Set From China
por: Jiang, Li, et al.
Publicado: (2015)

Comparison of survival outcomes of alcohol-related hepatocellular carcinoma with or without liver cirrhosis; a ten-year experience
por: Shin, Jongbeom, et al.
Publicado: (2019)

Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma
por: Ma, Qiang, et al.
Publicado: (2016)

Long non-coding RNA SNHG16 as a potential biomarker in hepatocellular carcinoma: A meta-analysis
por: Liu, Qiuli, et al.
Publicado: (2021)

Current treatment status and barriers for patients with chronic HCV infection in mainland China: A national multicenter cross-sectional survey in 56 hospitals
por: Bian, Dan-Dan, et al.
Publicado: (2017)

Development of a prognostic signature based on anoikis-related genes in hepatocellular carcinoma with the utilization of LASSO-cox method
por: Yu, Zhe, et al.
Publicado: (2023)

Association between relative liver enhancement on gadoxetic acid enhanced magnetic resonance images and histologic grade of hepatocellular carcinoma
por: Jin, Young-Joo, et al.
Publicado: (2017)

A novel immune signature to predict the prognosis of patients with hepatocellular carcinoma
por: Li, Qinghe, et al.
Publicado: (2021)

The effectiveness of tivantinib for MET-high hepatocellular carcinoma: A protocol for meta analysis
por: Wang, Yubin, et al.
Publicado: (2023)

Accuracy of gamma-glutamyl transpeptidase-to-platelet ratio (GPR), red cell distribution width (RDW), aspartate aminotransferase-to-platelet ratio index (APRI), and the fibrosis-4 index (FIB4) compared with liver biopsy in patients with drug-induced liver injury (DILI)
por: Wan, Minjie, et al.
Publicado: (2021)

Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of hepatocellular carcinoma (HCC)
por: Li, Mengting, et al.
Publicado: (2021)

Survival comparison between radiofrequency ablation and surgical resection for patients with small hepatocellular carcinoma: A systematic review and meta-analysis
por: Xuan, Dongchun, et al.
Publicado: (2021)

Sarcomatoid carcinoma of the common bile duct: A case report
por: Zhang, Shuisheng, et al.
Publicado: (2017)

Infiltrative Hepatocellular Carcinoma: Assessment of Factors Associated With Outcomes in Patients Undergoing Hepatectomy
por: Yan, Xiaopeng, et al.
Publicado: (2016)

Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A case report and review of the literature
por: Qu, Meng-Meng, et al.
Publicado: (2021)

Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survival
por: Jin, Chen, et al.
Publicado: (2017)

Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes
por: Huang, Ching-I, et al.
Publicado: (2018)

Nonalcoholic non-virus-related hepatocellular carcinoma arising from nonsteatotic liver: Clinical and pathological features
por: Shigematsu, Yasuyuki, et al.
Publicado: (2022)

Endoscopic radiofrequency ablation combined with fully covered self-expandable metal stent for inoperable periampullary carcinoma in a liver transplant patient: A case report
por: Tian, Qing, et al.
Publicado: (2017)

Postoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinoma
por: Peng, Wei, et al.
Publicado: (2016)

Pretreatment Neutrophil–Lymphocyte Ratio: An Independent Predictor of Survival in Patients With Hepatocellular Carcinoma
por: Gao, Fangyuan, et al.
Publicado: (2015)

Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: Transarterial Chemoembolization or Hepatic Resection?
por: Jianyong, Lei, et al.
Publicado: (2014)

Risk factors associated with late hepatocellular carcinoma detection in patients undergoing regular surveillance
por: Jang, Sangmi, et al.
Publicado: (2023)

Intestinal flora differences between patients with ulcerative colitis of different ethnic groups in China
por: Liu, Huan, et al.
Publicado: (2021)

Nomogram for individualized prediction of recurrence after postoperative adjuvant TACE for hepatitis B virus-related hepatocellular carcinoma
por: Jiang, Jiang, et al.
Publicado: (2017)

Geographical disparities in hepatitis b virus related hepatocellular carcinoma mortality rates worldwide from 1990 to 2019
por: Zhang, Nancy S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_anhm04trn9phelua4045bookgl